Market Exclusive

MEDITE CANCER DIAGNOSTICS, INC. (OTCMKTS:MDIT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

MEDITE CANCER DIAGNOSTICS, INC. (OTCMKTS:MDIT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January 23, 2018, the Board of Directors (the “Board”) of MEDITE Cancer Diagnostics, Inc. (the “Company”) accepted the resignation of Dr. Augusto Ocana from the position of Director of the Company effective immediately. Dr. Ocana’s resignation is without disagreement with the Company.

On January 25, 2018, the Board held a meeting and unanimously elected the Company’s Chief Executive Officer, Stephen Von Rump, to fill the Board position vacated by Dr. Ocana, to serve until his resignation or removal.

Item 9.01 Financial Statements and Exhibits

Exhibit No. Description

99.1

Resignation Letter of Dr. Augusto Ocana

Medite Cancer Diagnostics, Inc. ExhibitEX-99.1 2 ex99-1.htm LETTER Blueprint   EXHIBIT 99.1   Dr. Augusto Ocana Resignation Letter       January 23,…To view the full exhibit click here
About MEDITE CANCER DIAGNOSTICS, INC. (OTCMKTS:MDIT)
MEDITE Cancer Diagnostics, Inc. (MEDITE), formerly CytoCore, Inc., is a medical technology company engaged in the development, engineering, manufacturing and marketing of molecular biomarkers and medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions and related diseases. The Company develops, manufactures and sells a range of laboratory devices and consumable supplies for its target market in the histology and cytology cancer diagnostics segment. The Company offers a range of histology laboratory devices for processing tissue, from receiving the tissue in the laboratory to the final diagnosis. The Company offers USE33, an ultrasonic decalcification instrument that runs the process under controlled temperatures. The Company also offers TPC15 Duo or Trio, TES99, TES Valida, M530, A550, M380, TST44 and COT20 linear staining systems. In addition, the Company also offers RCM9000, ACS720 and TWISTER glass and robotic coverslippers.

Exit mobile version